Corbus Pharmaceuticals (CRBP) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.9
-1.53
-1.15
-0.78

Details

Expected EPS
-1.6566
Actual EPS
-1.9
Surprise EPS
-0.24
Surprise Percent
+14.69%

Description

Corbus Pharmaceuticals (CRBP) has reported earnings of -1.9 per share for Q4 2025.

0 Comments

Share your thoughts